| Product Code: ETC6747940 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Monogenetic Disease Therapy Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Monogenetic Disease Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 China Monogenetic Disease Therapy Market - Industry Life Cycle |
3.4 China Monogenetic Disease Therapy Market - Porter's Five Forces |
3.5 China Monogenetic Disease Therapy Market Revenues & Volume Share, By Inheritance Pattern, 2021 & 2031F |
3.6 China Monogenetic Disease Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 China Monogenetic Disease Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 China Monogenetic Disease Therapy Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 China Monogenetic Disease Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of monogenetic diseases in China |
4.2.2 Growing investments in research and development for monogenetic disease therapies |
4.2.3 Government initiatives to improve healthcare infrastructure and access to advanced treatments |
4.3 Market Restraints |
4.3.1 High cost of monogenetic disease therapies limiting affordability for patients |
4.3.2 Lack of awareness and understanding about monogenetic diseases among the general population |
4.3.3 Regulatory challenges and lengthy approval processes for new therapies |
5 China Monogenetic Disease Therapy Market Trends |
6 China Monogenetic Disease Therapy Market, By Types |
6.1 China Monogenetic Disease Therapy Market, By Inheritance Pattern |
6.1.1 Overview and Analysis |
6.1.2 China Monogenetic Disease Therapy Market Revenues & Volume, By Inheritance Pattern, 2021- 2031F |
6.1.3 China Monogenetic Disease Therapy Market Revenues & Volume, By Autosomal, 2021- 2031F |
6.1.4 China Monogenetic Disease Therapy Market Revenues & Volume, By Chromosomal, 2021- 2031F |
6.2 China Monogenetic Disease Therapy Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 China Monogenetic Disease Therapy Market Revenues & Volume, By Pharmacological, 2021- 2031F |
6.2.3 China Monogenetic Disease Therapy Market Revenues & Volume, By Surgical, 2021- 2031F |
6.2.4 China Monogenetic Disease Therapy Market Revenues & Volume, By Blood Transfusion, 2021- 2031F |
6.2.5 China Monogenetic Disease Therapy Market Revenues & Volume, By EBRT, 2021- 2031F |
6.2.6 China Monogenetic Disease Therapy Market Revenues & Volume, By Gene Therapies, 2021- 2031F |
6.2.7 China Monogenetic Disease Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Monogenetic Disease Therapy Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 China Monogenetic Disease Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3.3 China Monogenetic Disease Therapy Market Revenues & Volume, By SCID, 2021- 2031F |
6.3.4 China Monogenetic Disease Therapy Market Revenues & Volume, By Sickle Cell Anemia, 2021- 2031F |
6.3.5 China Monogenetic Disease Therapy Market Revenues & Volume, By Phenylketonuria, 2021- 2031F |
6.3.6 China Monogenetic Disease Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Monogenetic Disease Therapy Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 China Monogenetic Disease Therapy Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.3 China Monogenetic Disease Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 China Monogenetic Disease Therapy Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.5 China Monogenetic Disease Therapy Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.6 China Monogenetic Disease Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 China Monogenetic Disease Therapy Market Import-Export Trade Statistics |
7.1 China Monogenetic Disease Therapy Market Export to Major Countries |
7.2 China Monogenetic Disease Therapy Market Imports from Major Countries |
8 China Monogenetic Disease Therapy Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for monogenetic disease therapies |
8.2 Number of research publications and patents related to monogenetic disease treatments |
8.3 Adoption rate of genetic testing for early diagnosis and personalized treatment of monogenetic diseases |
9 China Monogenetic Disease Therapy Market - Opportunity Assessment |
9.1 China Monogenetic Disease Therapy Market Opportunity Assessment, By Inheritance Pattern, 2021 & 2031F |
9.2 China Monogenetic Disease Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 China Monogenetic Disease Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 China Monogenetic Disease Therapy Market Opportunity Assessment, By End users, 2021 & 2031F |
10 China Monogenetic Disease Therapy Market - Competitive Landscape |
10.1 China Monogenetic Disease Therapy Market Revenue Share, By Companies, 2024 |
10.2 China Monogenetic Disease Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here